Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn-Reference-Cited by-同舟云学术

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn

Published:2018-02 Issue:2 Volume:88 Page:89-99
ISSN:1695-4033
Container-title:Anales de Pediatría
language:es
Short-container-title:Anales de Pediatría

Author:

Navas-López Víctor Manuel,Pujol Muncunill Gemma,Llerena Enrique,Navalón Rubio María,Gil-Ortega David,Varea-Calderón Vicente,Sierra Salinas Carlos,Martin-de-Carpi Javier

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference40 articles.

1. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): The SPIRIT Registry;Martín-de-Carpi;Inflamm Bowel Dis,2013

2. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): The EXPERIENCE registry;Martín-de-Carpi;J Crohns Colitis,2014

3. ECCO/ESPGHAN, Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease;Ruemmele;J Crohns Colitis,2014

4. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: Evaluation of the Porto IBD group growth relapse and outcomes with therapy (GROWTH CD) study;Levine;Inflamm Bowel Dis,2014

5. Adalimumab treatment in children with refractory Crohn's disease;Rosenbach;Dig Dis Sci,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing “Top-Down” and “Step-Up” Strategies;Journal of Pediatric Gastroenterology & Nutrition;2022-10-28

2. Adalimumab in Pediatric Inflammatory Bowel Disease;Frontiers in Pediatrics;2022-04-13

3. Anthocyanin composition of fruit extracts from Lycium ruthenicum and their protective effect for gouty arthritis;Industrial Crops and Products;2019-03